GIP
AZN icon

Greatmark Investment Partners’s AstraZeneca AZN Stock Holding History

Greatmark Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Hold
1,821
– – 0.04% 128
2026
Q1 		$359K Sell
1,821
-1
-0.1% -$193 0.04% 112
2025
Q4 		$335K Hold
1,822
– – 0.04% 119
2025
Q3 		$279K Hold
1,822
– – 0.03% 123
2025
Q2 		$255K Hold
1,822
– – 0.03% 127
2025
Q1 		$268K Hold
1,822
– – 0.04% 121
2024
Q4 		$239K Buy
+1,822
New +$255K 0.03% 128

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Greatmark Investment Partners's AZN Position: Q2 2026 in Review

Greatmark Investment Partners held its AstraZeneca (AZN) position steady in Q2 2026 at 1,821 shares worth $345K. The position accounts for 0.04% of the portfolio, ranked #128.

Greatmark Investment Partners first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $359K in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Greatmark Investment Partners held 1,821 shares of AstraZeneca worth $345K as of Q2 2026.
  • Greatmark Investment Partners left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.04% of Greatmark Investment Partners's portfolio in Q2 2026, its #128 holding.
  • Greatmark Investment Partners first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Greatmark Investment Partners's AstraZeneca position peaked at $359K in Q1 2026.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.